INCIDENCE AND PREDICTIVE FACTORS OF HBsAg LOSS IN HBEAG-POSITIVE PATIENTS WHO STOP NUCLEOT(S)IDE ANALOGUE THERAPY

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalHepatology
Volume76
StatePublished - 2022

Cite this